Literature DB >> 35783307

Simultaneous Onset of Pediatric Systemic Lupus Erythematosus in Twin Brothers: Case Report.

Rinat K Raupov1,2,3, Evgeny N Suspitsin4,5, Artur I Imelbaev6, Mikhail M Kostik1.   

Abstract

There are hundreds of twin adult patients with systemic lupus erythematosus (SLE), but male children with SLE are rarely affected. Two monozygotic twin brothers developed SLE at the age of 11 years during 1 month. The index brother manifested with Henoch-Shonlein purpura, accompanied by ANA positivity, and later developed critical left femoral arterial stenosis with high levels of anti-dsDNA, antiphospholipid antibodies, hypocomplementemia, and Coombs-positive hemolytic anemia. At that time his twin brother had only identical autoimmune findings and developed clinical manifestation (myositis and fasciitis) a month later. Both twins had increased IFN-score and shared a heterozygous variant in the RNASEL gene. Index patients developed scalp rash and nephritis 6 months after their parents refused the treatment which has been lasted for 1 year after disease diagnostics.
Conclusion: The simultaneous onset of the pediatric SLE in the male twin is a very rare situation suspected monogenic origin of the disease. Further functional studies are required to confirm the causative role of the mutation.
Copyright © 2022 Raupov, Suspitsin, Imelbaev and Kostik.

Entities:  

Keywords:  IFN-signature; RNASEL; antiphospholipid syndrome; pediatric systemic lupus erythematosus; twins

Year:  2022        PMID: 35783307      PMCID: PMC9243501          DOI: 10.3389/fped.2022.929358

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.569


  18 in total

1.  Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives.

Authors:  S V Navarra; M I Ishimori; E A Uy; L Hamijoyo; J Sama; J A James; V M Holers; M H Weisman
Journal:  Lupus       Date:  2010-12-23       Impact factor: 2.911

2.  Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort.

Authors:  Constance Jensina Ulff-Møller; Anders Jørgen Svendsen; Louise Nørgaard Viemose; Søren Jacobsen
Journal:  Semin Arthritis Rheum       Date:  2017-06-23       Impact factor: 5.532

3.  Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline.

Authors:  Kalliopi Klavdianou; Argyro Lazarini; Antonis Fanouriakis
Journal:  BioDrugs       Date:  2020-04       Impact factor: 5.807

Review 4.  Monogenic lupus: it's all new!

Authors:  Patricia Costa-Reis; Kathleen E Sullivan
Journal:  Curr Opin Immunol       Date:  2017-10-27       Impact factor: 7.486

Review 5.  Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.

Authors:  Isabelle Melki; Marie-Louise Frémond
Journal:  Curr Rheumatol Rep       Date:  2020-06-16       Impact factor: 4.592

6.  Whole-genome sequencing identifies rare missense variants of WNT16 and ERVW-1 causing the systemic lupus erythematosus.

Authors:  Jianhai Chen; Ping Zhang; Haidi Chen; Xin Wang; Xuefei He; Jie Zhong; HuaPing Zheng; Xiaoyu Li; Ivan Jakovlić; Yong Zhang; Younan Chen; Bairong Shen; Cheng Deng; Yongkang Wu
Journal:  Genomics       Date:  2022-03-10       Impact factor: 5.736

7.  Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.

Authors:  Ezgi Deniz Batu; Can Koşukcu; Ekim Taşkıran; Sezgin Sahin; Sema Akman; Betül Sözeri; Erbil Ünsal; Yelda Bilginer; Ozgur Kasapcopur; Mehmet Alikaşifoğlu; Seza Ozen
Journal:  J Rheumatol       Date:  2018-07-15       Impact factor: 4.666

8.  Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.

Authors:  Lu Gan; Terrance P O'Hanlon; Aaron S Gordon; Lisa G Rider; Frederick W Miller; Peter D Burbelo
Journal:  BMC Musculoskelet Disord       Date:  2014-03-06       Impact factor: 2.362

9.  Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations.

Authors:  Eleni Palli; Evrydiki Kravvariti; Maria G Tektonidou
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

Review 10.  Interferon pathway in SLE: one key to unlocking the mystery of the disease.

Authors:  Lars Rönnblom; Dag Leonard
Journal:  Lupus Sci Med       Date:  2019-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.